维普中文期刊产品整合服务
18篇 您的检索式:作者名="Karppi P"
    题名 作者 年代 出处 被引量
1Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hipfracture显示文摘Huusko TM Karppi P Kautiainen H 2002Calcif Tissue Int2002,71,:1
2Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum 显示文摘Vahonen P Karppi J Nyyssonen K 2005J Chromatogr B2005,828,12:1
3Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland 显示文摘Huusko T M Korpela M Karppi P 2001Ann Rheum Dis2001,60,:1
4Random- ized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture 显示文摘Huusko TM Karppi P Kautiainen H 2002Calcif Tissue Int2002,71,:1
5Randomized double-blind, clinically controlled trial of intranasal calcitonnin treatment in patients with hip fracture显示文摘Huusko TM Karppi P Kautiainen H 0,,06:1
6Randomized, doubleblind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture 显示文摘Huusko TM Karppi P Kautiainen H 2002Calcif Tissue Int2002,71,6:1
7Clinically controlled trial of intranasal calitonin treatment in patients with hip fracture显示文摘Huusko T Karppi P Kautiainen H 2002Calcif Tissue International2002,71,6:1
8Incidence of second hip fractures A population-based study显示文摘Lonnroos E Kautiainen H Karppi P 2007Osteoporosis international2007,18,9:1
9Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture显示文摘Huusko TM Karppi P Kautiainen H 2002Calcif Tissue Int2002,71,6:1
10Comparison of HP1C method and commercial EIISA assay for asymmetric dimethylarginine (ADMA) determination in human serum显示文摘Vahonen P Karppi J Nyyssonen K 2005J Chromatogr B Analyt Technol Biomed life Sci2005,828,12:1
11Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarg-nine (ADMA) determination in human serum 显示文摘Valtonen P Karppi J Nyyssonen K 2005J Chromatogr B Analyt Teehnol Biomed Life Sei2005,828,12:1
12Randomized,double-blind,clinically controlled trial of intranasal calcitonintreatment in patients with hip fracture显示文摘Huusko TM Karppi P Kautiainen H 2002Calcif Tissue Int2002,71,6:1
13Randomized,doubleblind,clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture显示文摘Huusko TM Karppi P Kautiainen H 0,,6:1
14Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland 显示文摘Huusko TM Korpela M Karppi P 2001Ann Rheum Dis2001,60,5:1
15Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture 显示文摘Huusko TM Karppi P 2002Calcif Tissue Int2002,71,6:1
16Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture显示文摘Huusko TM Karppi P Kautiainen H 2002Calcif Tissue Int2002,71,6:1
17Neurepsychiatrie symptoms and quality of life in patients with very mild and mild Alzheimer's disease显示文摘Karttunen K Karppi P Hihunen A 2011Int J Geriatr Psychiatry2011,26,5:1
18Comparison of HPLCmethod and commercial ELISA assay for asymmetric dimethylarginine(ADMA)determination in human serum显示文摘Valtonen P Karppi J Nyyssonen K 2005J Chromatogr BAnalyt Technol Biomed Life Sci2005,828,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费